- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Menopausal hormone therapy
- Meeting Date: November 2024
- Public Summary Document (PSD) November 2024 PBAC Meeting - (PDF 1MB)
- Public Summary Document (PSD) November 2024 PBAC Meeting - (Word 198KB)
Related Public Summary Documents
